Associate Professor, Medicine, University of Wisconsin Medical School
Hematology
Dr. Natalie S. Callander, MD
|
|
Give Review
Dr. Natalie S. Callander is an expert in the field of Hematology. She researched medicine at Tufts University School of Medicine. Tufts University School of Medicine is ranked 49/52 in Research/PrimaryCare. She received awards:"CMS Meaningful Use Stage 1 Certification". Natalie Callander is a published doctor as well. She has 51 publications published. The latest was: What''s in a name. Natalie S. Callander, MD is registered with Medicare and accepts Medicare payments.
Publications
- Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.
- Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single agent activity in patients With relapsed multiple myeloma.
- Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients With relapsed or refractory multiple myeloma treated With borte...
- Older Patients With Myeloma Derive Similar Benefit from Autologous Transplantation.
- TPL2 kinase regulates the inflammatory milieu of the Myeloma niche.
- Macrophages in multiple Myeloma: emerging concepts and therapeutic implications.
- MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-Associated monocytes/macrophages.
- Macrophages and mesenchymal stromal Cells support survival and proliferation of multiple myeloma Cells.
- Microscale functional cytomics for studying hematologic Cancers.
- Impact of high-risk classification by FISH: an Eastern Cooperative Oncology Group (ECOG) study E4A03.
- Impact of gene expression profiling-based risk stratification in patients With myeloma receiving initial therapy With lenalidomide and dexamethasone.
- VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell Lymphoma: a Wisconsin Oncology Network study.
- Trends in allogeneic stem Cell transplantation for multiple myeloma: a Center for International Blood and Marrow Transplant Research (CIBMTR) analysis.
- Bortezomib-resistant nuclear factor-kappaB activity in multiple myeloma Cells.
- Thalidomide maintenance following high-dose melphalan With autologous stem cell support in myeloma.
- Denileukin diftitox for the treatment of steroid-resistant Acute graft-versus-host disease.
- Severe, late-onset Graft-versus-host disease in a liver transplant recipient documented by chimerism analysis.
- IL-3 expression by myeloma Cells increases both osteoclast formation and growth of myeloma Cells.
- AML-1A and AML-1B regulation of MIP-1alpha expression in multiple Myeloma.
- Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple Myeloma: phase 1 results from the multicenter EVOLUTION study.
- Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem Cell transplant patients: results of a prospective, double-blind, randomized trial.
- Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation.
- Manometric assessment of the effect of the diaphragmatic crural sling in gastro-oesophageal reflux: implications for surgical management.
- Laparoscopic ''physiological'' antireflux procedure: preliminary results of a prospective symptomatic and objective study.
- Acute chemical meningitis after metrizamide-lumbar myelography.
- Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with Myeloid metaplasia with myelofibrosis.
- Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's Lymphoma patients: a rando...
- Integrated sexual healthcare: the development and review of one model of service deLivery.
- An audit of chlamydia treatment and contact tracing in a sexual health service.
- Successful PBSC mobilization With high-dose G-CSF for patients failing a first round of mobilization.
- What''s in a name.
- Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial.
- Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic Diseases: the Texas Transplant Co...
- Myeloma bone Disease.
- Registry results and high-dose therapy.
- Treatment of oral Chronic graft-versus-host disease with PUVA therapy: case report and literature review.
- Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured Cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor...
- Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive Disease of the liver in allogeneic bone marrow transplant patients.
- Immunohistochemical identification of tissue factor in solid Tumors.
- Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for Lymphoma and multiple myeloma.
- Performance of a hybrid central venous catheter utilized for both peripheral blood stem Cell harvest and transplant support of patients undergoing autologous periphera...
- Negative regulation of the tumor suppressor p53 gene by microRNAs.
- In Anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2.
- Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients wit...
- Phase III randomised study of dexamethasone With or Without oblimersen sodium for patients With advanced multiple myeloma.
- Paclitaxel and filgrastim for hematopoietic progenitor cell mobilization in patients with Hematologic malignancies after failure of a prior mobilization regimen.
- Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian Cancer in first remission or chem...
- MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma Cells to marrow stromal Cells.
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple Myeloma: an open-label random...
- Bone marrow stromal Cells from multiple myeloma patients uniquely induce bortezomib resistant NF-kappaB activity in myeloma Cells.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Bladder Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of California San Diego -
NYU School of Medicine -
Tufts University School of Medicine
Hospital
-
University of Wisconsin Hospital and Clinics -
William S. Middleton Memorial Veterans Hospital
Drug Facts
| NPI NUMBER | 1649247339 | |
| NPPES Provider LastName | CALLANDER | |
| NPPES Provider FirstName | NATALIE | |
| NPPES Provider ZIPCode | 53792 | |
| NPPES Provider State | WI | |
| Specialty Description | Hematology | |
| Total Claim Count | 1336.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 100.0 | |
| Percent Opioid Claims | 7.49 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1649247339 |
| Last Name Of The Provider | CALLANDER |
| First Name Of The Provider | NATALIE |
| View All |
Similar Doctors
|
|
Dr. Shannon E. O'Mahar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Huie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vaishalee P. Kenkre, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward J. Prendergast, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa M. Lepeak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justine Y. Bruce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Glenn Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua M. Lang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter A. Beatty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kae I. Walker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yamil M. Arbaje, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ticiana B. Leal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alissa A. Weber, MD
This Doctor is OpenDoctor Recommended.
|